← Leaderboards
Kaloyan M. Tsanov
Sloan-Kettering Inst Can Research
$519,696
Attributed
$519,696
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2022–25$250K$187.5K$125K$62.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$519,696 · 2
By mechanism
K99$270,696 · 1
R00$249,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Luisa Escobar Hoyos$5,863,708
- Tuomas Tammela$7,490,282
- Scott W Lowe$63,222,126
- Xuejun Jiang$14,685,146
- Olca Basturk$476,493
Others in their field
Other Rising Stars on “Advisory Committees”
- Brian Zavertnik · Palantir Technologies, Inc.$33,059,912
- Johanna Marizan-Ho · Palantir Technologies, Inc.$9,612,691
- Frank A Provenzano · St. Joseph'S Hospital And Medical Center$8,533,907
- Brian Todd Schaneberg · Illinois Institute Of Technology$6,784,113
- Burton Rochelson · Feinstein Institute For Medical Research$5,891,324
- Christine O'Connell · H. Lee Moffitt Cancer Ctr & Res Inst$5,494,823
Research focus
Advisory CommitteesAffectAreaAwardCancer BiologyCancer CellCancer TypeCareerCareer DevelopmentCatalogsCd8-Positive T-LymphocytesCdkn2a GeneCellsCollaborative EnvironmentCombinatorialCrispr/Cas TechnologyDevelopment PlansEnsureEnvironmentEpigenomicsEventEvolutionFacultyAdvanced Disease
Grant awards (3)
Elucidating determinants of metastasis suppression in pancreatic cancer$249,000
R00 · FY2025 · CA · contact PI
Elucidating determinants of metastasis suppression in pancreatic cancer$135,348
K99 · FY2023 · CA · contact PI
Elucidating determinants of metastasis suppression in pancreatic cancer$135,348
K99 · FY2022 · CA · contact PI